The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.
Publication year
2009Source
Minerva Endocrinologica, 34, 1, (2009), pp. 57-69ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Nuclear Medicine
Journal title
Minerva Endocrinologica
Volume
vol. 34
Issue
iss. 1
Page start
p. 57
Page end
p. 69
Subject
ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detectionAbstract
Radioiodine plays an important role in the treatment of thyroid cancer. It is used for thyroid remnant ablation as well as for treatment of metastatic disease. Despite the fact that it is used all over the world for these indications, the exact administered dose is still a subject for DISCUSSION: Two methods are widely available: the so-called fixed empiric method and the dosimetric one. This review will highlight the aspects of radioiodine in treatment of thyroid cancer and discuss the advantages and disadvantages of the several methods for the calculation of the administered dose.
This item appears in the following Collection(s)
- Academic publications [227693]
- Faculty of Medical Sciences [86198]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.